申请人:IRONWOOD PHARMACEUTICALS INC
公开号:WO2014047325A1
公开(公告)日:2014-03-27
The present patent application discloses at least the compounds according to Formula I or Formula lb shown below, or pharmaceutically acceptable salts thereof, wherein ring B, JB, n, JD, J, o, X, RC and RA are as described herein.